Feb 1, 2018 Roth Capital Partners Acts as Financial Advisor to GT Biopharma Inc. (OTCQB: GTBP and Euronext Paris: GTBP.PA) in its $7.1 Million Private Placement Roth Capital Partners
Jan 31, 2018 Roth Capital Partners Acts as Co-Manager for Albireo Pharma, Inc. (ALBO) in its $74.7 Million Follow-On Roth Capital Partners
Jan 30, 2018 Roth Capital Partners Acts as Joint Book-Running Manager for Eyenovia Inc. (EYEN) in its $27.3 Million IPO Roth Capital Partners
Jan 29, 2018 Roth Capital Partners Acts as Co-Manager for Stemline Therapeutics, Inc. (STML), in its $59.6 Million Follow-On Roth Capital Partners
Jan 9, 2018 Roth Capital Partners Acts as Sole Placement Agent for Radisys Corporation (NASDAQ: RSYS) in its $17 Million Senior Notes Financing Roth Capital Partners
Jan 3, 2018 Roth Capital Partners Acts as Sole Book-Running Manager for iClick Interactive Asia Group Limited (NASDAQ:ICLK) in its $34.5 Million IPO Roth Capital Partners
Jan 3, 2018 Roth Capital Partners Expands Technology Practice with Addition of Scott Searle, CFA, Managing Director, Senior Research Analyst and transition of Brian Alger, CFA to Managing Director, Investment Banking Business Wire
Dec 22, 2017 Roth Capital Partners Acts as Co-Manager for Madrigal Pharmaceuticals, Inc. (MDGL) in its $143.7 Million Follow-On Roth Capital Partners
